Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Healthcare Biotechnology
Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc > WILL VIR BIOTECHNOLOGY" (NASDAQ - VIR) TAKE OVER MICROBIX?
View:
Post by modulex on Jan 08, 2022 12:10pm

WILL VIR BIOTECHNOLOGY" (NASDAQ - VIR) TAKE OVER MICROBIX?

Vir Biotechnology (NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech. 
Comment by RazeKreations on Jan 08, 2022 1:49pm
Can you explain that headline? MBX owns the rights to Kinlytic outright. I believe that is the only "drug" that Microbix owns. Everything else is for quality control (Qap's) testing (antigens) storage and transportation (Dxtm)
Comment by wizzdumb on Jan 08, 2022 3:42pm
They are just spamming. 
Comment by RazeKreations on Jan 08, 2022 4:08pm
Yes i suspected that. Thats why the question. Things sure are quiet. May be this way until until Robert McWhirter , Eden Rahim or some other fund managers get onboard with recommdations
Comment by modulex on Jan 09, 2022 11:52am
VIR Biotechnology from San Francisco is quite an interesting public company to consider acquiring MBX.  If you listen to the following link featuring Cameron Groome in November 2021 https://www.youtube.com/watch?v=k88pqRtNvEk, he is clearly setting the stage for a rewarding sale or merger of Microbix. Vir Biotechnology is a clinical-stage immunology company focused on combining ...more  
Microbix Biosystems Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities